Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study assessed the long term safety data for the use of tobramycin inhalation powder in
patients suffering from cystic fibrosis who have a chronic pulmonary infection with
Pseudomonas aeruginosa.